Literature DB >> 8023671

The effects of wound infiltration with bupivacaine versus saline on postoperative pain and opioid requirements after herniorrhaphy.

G W Dierking1, E Ostergaard, H T Ostergård, J B Dahl.   

Abstract

In a prospective, double-blind, placebo-controlled study, twenty-eight healthy, male patients, aged 20-69 years, scheduled for unilateral elective inguinal herniorrhaphy ad modum Bassini were randomized to receive postoperative infiltration of the surgical wound with either bupivacaine 0.25%, or isotonic saline. General anaesthesia was induced with thiopentone 3-5 mg.kg-1 and alfentanyl 10 micrograms.kg-1, and maintained with alfentanyl 5 micrograms.kg-1 15 min and N2O/O2. After herniorrhaphy, the internal fascia was infiltrated with bupivacaine 0.25% or saline, 10 ml. After closure of the external fascia, the subcutaneous tissue was infiltrated with bupivacaine 0.25% or saline, 15 ml on both sides of the surgical wound. Pain at rest, during mobilisation and during cough was significantly decreased in patients receiving bupivacaine compared to placebo. Median time to first request for morphine was increased from 25 min to 135 min, and the consumption of supplementary morphine during the 24 h study period reduced from four to two doses of 0.1 mg.kg-1 iv or 0.125 mg.kg-1 im, in patients who received bupivacaine compared to placebo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023671     DOI: 10.1111/j.1399-6576.1994.tb03891.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

1.  Anatomical bases of prolonged ilio-inguinal-hypogastric regional anesthesia.

Authors:  Frédérique Peschaud; Robert Malafosse; Patrice Le Floch-Prigent; Carole Coste-See; Bernard Nordlinger; Vincent Delmas
Journal:  Surg Radiol Anat       Date:  2006-09-29       Impact factor: 1.246

Review 2.  [Inguinal and femoral hernia repair].

Authors:  B Geissler; M Anthuber
Journal:  Chirurg       Date:  2011-05       Impact factor: 0.955

3.  European Hernia Society guidelines on the treatment of inguinal hernia in adult patients.

Authors:  M P Simons; T Aufenacker; M Bay-Nielsen; J L Bouillot; G Campanelli; J Conze; D de Lange; R Fortelny; T Heikkinen; A Kingsnorth; J Kukleta; S Morales-Conde; P Nordin; V Schumpelick; S Smedberg; M Smietanski; G Weber; M Miserez
Journal:  Hernia       Date:  2009-07-28       Impact factor: 4.739

4.  Preperitoneal bupivacaine attenuates pain following laparoscopic inguinal hernia repair.

Authors:  A Bar-Dayan; M Natour; B Bar-Zakai; O Zmora; M Shabtai; A Ayalon; J Kuriansky
Journal:  Surg Endosc       Date:  2004-05-27       Impact factor: 4.584

5.  International guidelines for groin hernia management.

Authors: 
Journal:  Hernia       Date:  2018-01-12       Impact factor: 4.739

6.  A prospective, randomized, comparative trial of a COX-2 selective nonsteroidal anti-inflammatory drug versus placebo in inguinal herniorrhaphy patients.

Authors:  M J Schurr; L D Faucher
Journal:  Hernia       Date:  2009-03-20       Impact factor: 4.739

7.  Investigating the effect of intra-operative infiltration with local anaesthesia on the development of chronic postoperative pain after inguinal hernia repair. A randomized placebo controlled triple blinded and group sequential study design [NCT00484731].

Authors:  Philipp Honigmann; Henning Fischer; Anita Kurmann; Laurent Audigé; Guido Schüpfer; Jürg Metzger
Journal:  BMC Surg       Date:  2007-11-06       Impact factor: 2.102

Review 8.  Impact of volume expansion on the efficacy and pharmacokinetics of liposome bupivacaine.

Authors:  Admir Hadzic; John A Abikhaled; William J Harmon
Journal:  Local Reg Anesth       Date:  2015-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.